<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36220361</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8600</ISSN><JournalIssue CitedMedium="Internet"><Volume>137</Volume><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Metabolism: clinical and experimental</Title><ISOAbbreviation>Metabolism</ISOAbbreviation></Journal><ArticleTitle>Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>155330</StartPage><MedlinePgn>155330</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.metabol.2022.155330</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0026-0495(22)00208-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">COVID-19 might be a risk factor for various chronic diseases. However, the association between COVID-19 and the risk of incident diabetes remains unclear. We aimed to meta-analyze evidence on the relative risk of incident diabetes in patients with COVID-19.</AbstractText><AbstractText Label="METHODS">In this systematic review and meta-analysis, the Embase, PubMed, CENTRAL, and Web of Science databases were searched from December 2019 to June 8, 2022. We included cohort studies that provided data on the number, proportion, or relative risk of diabetes after confirming the COVID-19 diagnosis. Two reviewers independently screened studies for eligibility, extracted data, and assessed risk of bias. We used a random-effects meta-analysis to pool the relative risk with corresponding 95&#xa0;% confidence intervals. Prespecified subgroup and meta-regression analyses were conducted to explore the potential influencing factors. We converted the relative risk to the absolute risk difference to present the evidence. This study was registered in advance (PROSPERO CRD42022337841).</AbstractText><AbstractText Label="MAIN FINDINGS">Ten articles involving 11 retrospective cohorts with a total of 47.1 million participants proved eligible. We found a 64&#xa0;% greater risk (RR&#xa0;=&#xa0;1.64, 95%CI: 1.51 to 1.79) of diabetes in patients with COVID-19 compared with non-COVID-19 controls, which could increase the number of diabetes events by 701 (558 more to 865 more) per 10,000 persons. We detected significant subgroup effects for type of diabetes and sex. Type 2 diabetes has a higher relative risk than type 1. Moreover, men may be at a higher risk of overall diabetes than women. Sensitivity analysis confirmed the robustness of the results. No evidence was found for publication bias.</AbstractText><AbstractText Label="CONCLUSIONS">COVID-19 is strongly associated with the risk of incident diabetes, including both type 1 and type 2 diabetes. We should be aware of the risk of developing diabetes after COVID-19 and prepare for the associated health problems, given the large and growing number of people infected with COVID-19. However, the body of evidence still needs to be strengthened.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Honghao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China; Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Manli</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nanjing University of Chinese Medicine, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Mingyao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Evidence-Based Nursing Center, School of Nursing, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Bei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Quan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Ambulatory Surgery Center, Xijing Hospital, Air Force Military Medical University, Xi'an, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Jinhui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Guowu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China; Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kehu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China; Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xuping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China; Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, China. Electronic address: songxp@lzu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China; Department of Social Medicine and Health Management, School of Public Health, Lanzhou University, Lanzhou, China; Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou, China. Electronic address: gelong2009@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Metabolism</MedlineTA><NlmUniqueID>0375267</NlmUniqueID><ISSNLinking>0026-0495</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Public health</Keyword></KeywordList><CoiStatement>Declaration of competing interest All authors have no conflicts of interest relevant to this article to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>11</Day><Hour>21</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36220361</ArticleId><ArticleId IdType="pmc">PMC9546784</ArticleId><ArticleId IdType="doi">10.1016/j.metabol.2022.155330</ArticleId><ArticleId IdType="pii">S0026-0495(22)00208-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins University  Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html</Citation></Reference><Reference><Citation>Scherer P.E., Kirwan J.P., Rosen C.J. Post-acute sequelae of COVID-19: a metabolic perspective. Elife. 2022;11 doi: 10.7554/elife.78200.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/elife.78200</ArticleId><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyu H.H., Bachman V.F., Alexander L.T., et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ. 2016;i3857 doi: 10.1136/bmj.i3857. Published online.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i3857</ArticleId><ArticleId IdType="pmc">PMC4979358</ArticleId><ArticleId IdType="pubmed">27510511</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Magliano D.J., Zimmet P.Z. The worldwide epidemiology of type 2 diabetes mellitus&#x2013;present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228&#x2013;236. doi: 10.1038/nrendo.2011.183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2011.183</ArticleId><ArticleId IdType="pubmed">22064493</ArticleId></ArticleIdList></Reference><Reference><Citation>International Diabetes Federation  . 2019. IDF Diabetes Atlas 9th Edition.https://diabetesatlas.org</Citation></Reference><Reference><Citation>Feldman E.L., Savelieff M.G., Hayek S.S., Pennathur S., Kretzler M., Pop-Busui R. COVID-19 and diabetes: a collision and collusion of two diseases. Diabetes. 2020;69(12):2549&#x2013;2565. doi: 10.2337/dbi20-0032.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dbi20-0032</ArticleId><ArticleId IdType="pmc">PMC7679769</ArticleId><ArticleId IdType="pubmed">32938731</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C., Schwarz P.E.H., Ludwig B., et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021;9(11):786&#x2013;798. doi: 10.1016/S2213-8587(21)00244-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00244-8</ArticleId><ArticleId IdType="pmc">PMC8489878</ArticleId><ArticleId IdType="pubmed">34619105</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamer M., Gale C.R., Batty G.D. Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: population-based, prospective cohort study. Metabolism. 2020;112 doi: 10.1016/j.metabol.2020.154344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154344</ArticleId><ArticleId IdType="pmc">PMC7442562</ArticleId><ArticleId IdType="pubmed">32835758</ArticleId></ArticleIdList></Reference><Reference><Citation>Barron E., Bakhai C., Kar P., et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8(10):813&#x2013;822. doi: 10.1016/S2213-8587(20)30272-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30272-2</ArticleId><ArticleId IdType="pmc">PMC7426088</ArticleId><ArticleId IdType="pubmed">32798472</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L., She Z.G., Cheng X., et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020;31(6):1068&#x2013;1077.e3. doi: 10.1016/j.cmet.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7252168</ArticleId><ArticleId IdType="pubmed">32369736</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Tian S., Chen T., et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab. 2020;22(10):1897&#x2013;1906. doi: 10.1111/dom.14099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14099</ArticleId><ArticleId IdType="pmc">PMC7283710</ArticleId><ArticleId IdType="pubmed">32469464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062. doi: 10.1016/s0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T., Kapoor N., Cao Y., Tapp R.J., Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021;23(3):870&#x2013;874. doi: 10.1111/dom.14269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14269</ArticleId><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino F., Amiel S.A., Zimmet P., et al. New-onset diabetes in covid-19. N Engl J Med. 2020;383(8):789&#x2013;790. doi: 10.1056/NEJMc2018688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2018688</ArticleId><ArticleId IdType="pmc">PMC7304415</ArticleId><ArticleId IdType="pubmed">32530585</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddu S.K., Aurangabadkar G., Kuchay M.S. New onset diabetes, type 1 diabetes and COVID-19. Diabetes Metab Syndr. 2020;14(6):2211&#x2013;2217. doi: 10.1016/j.dsx.2020.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.11.012</ArticleId><ArticleId IdType="pmc">PMC7669477</ArticleId><ArticleId IdType="pubmed">33395782</ArticleId></ArticleIdList></Reference><Reference><Citation>Metwally A.A., Mehta P., Johnson B.S., Nagarjuna A., Snyder M.P. COVID-19-induced new-onset diabetes: trends and technologies. Diabetes. 2021;70(12):2733&#x2013;2744. doi: 10.2337/dbi21-0029.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dbi21-0029</ArticleId><ArticleId IdType="pmc">PMC8660988</ArticleId><ArticleId IdType="pubmed">34686519</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1&#x2013;e34. doi: 10.1016/j.jclinepi.2009.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.006</ArticleId><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2013;2012. doi: 10.1001/jama.283.15.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M., Hammady H., Fedorowicz Z., Elmagarmid A. Rayyan&#x2014;a web and mobile app for systematic reviews. Syst Rev. 2016;5(1) doi: 10.1186/s13643-016-0384-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Evidence Partners  Tool to assess risk of bias in cohort studies. https://www.evidencepartners.com/resources/methodological-resources/tool-to-assess-risk-of-bias-in-cohort-studies-distillersr</Citation></Reference><Reference><Citation>DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane. 2022. www.training.cochrane.org/handbook Available from.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;cker G., Schwarzer G., Carpenter J.R., Schumacher M. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8(1):79. doi: 10.1186/1471-2288-8-79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-8-79</ArticleId><ArticleId IdType="pmc">PMC2648991</ArticleId><ArticleId IdType="pubmed">19036172</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemieniuk R.A., Bartoszko J.J., Zeraatkar D., et al. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020;370 doi: 10.1136/bmj.m2980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2980</ArticleId><ArticleId IdType="pmc">PMC7390912</ArticleId><ArticleId IdType="pubmed">32732190</ArticleId></ArticleIdList></Reference><Reference><Citation>Wander P.L., Lowy E., Beste L.A., et al. The incidence of diabetes among 2,777,768 veterans with and without recent SARS-CoV-2 infection. Diabetes Care. 2022;45(4):782&#x2013;788. doi: 10.2337/dc21-1686.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1686</ArticleId><ArticleId IdType="pmc">PMC9016731</ArticleId><ArticleId IdType="pubmed">35085391</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietropaolo M., Hotez P., Giannoukakis N. Incidence of an insulin-requiring hyperglycemic syndrome in SARS CoV-2-infected young individuals: is it type 1 diabetes? Diabetes. 2022 doi: 10.2337/db21-0831. Published online.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db21-0831</ArticleId><ArticleId IdType="pmc">PMC9862279</ArticleId><ArticleId IdType="pubmed">35293987</ArticleId></ArticleIdList></Reference><Reference><Citation>Birabaharan M., Kaelber D.C., Pettus J.H., Smith D.M. Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: a cohort study. Diabetes Obes Metab. 2022;24(6):1176&#x2013;1179. doi: 10.1111/dom.14659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dom.14659</ArticleId><ArticleId IdType="pmc">PMC9035030</ArticleId><ArticleId IdType="pubmed">35112782</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373 doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K., Ren S., Heath K., et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2022;376 doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeigue P.M., McGurnaghan S., Blackbourn L., et al. bioRxiv; 2022. Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland. Published online.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.11.22270785</ArticleId><ArticleId IdType="pubmed">35880797</ArticleId></ArticleIdList></Reference><Reference><Citation>Qeadan F., Tingey B., Egbert J., et al. The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: a nationwide cohort from the US using the Cerner Real-World Data. PLoS One. 2022;17(4) doi: 10.1371/journal.pone.0266809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0266809</ArticleId><ArticleId IdType="pmc">PMC9017888</ArticleId><ArticleId IdType="pubmed">35439266</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett C.E., Koyama A.K., Alvarez P., et al. Risk for newly diagnosed diabetes &gt;30 days after SARS-CoV-2 infection among persons aged &lt;18 years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):59&#x2013;65. doi: 10.15585/mmwr.mm7102e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7102e2</ArticleId><ArticleId IdType="pmc">PMC8757617</ArticleId><ArticleId IdType="pubmed">35025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372 doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W., Kuss O., Kostev K. Incidence of newly diagnosed diabetes after Covid-19. Diabetologia. 2022;65(6):949&#x2013;954. doi: 10.1007/s00125-022-05670-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-022-05670-0</ArticleId><ArticleId IdType="pmc">PMC8923743</ArticleId><ArticleId IdType="pubmed">35292829</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller D.R., Safford M.M., Pogach L.M. Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care. 2004;27(Suppl 2):B10&#x2013;B21. doi: 10.2337/diacare.27.suppl_2.b10.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diacare.27.suppl_2.b10</ArticleId><ArticleId IdType="pubmed">15113777</ArticleId></ArticleIdList></Reference><Reference><Citation>Spick M., Lewis H.M., Wilde M.J., Hopley C., Huggett J., Bailey M.J. Systematic review with meta-analysis of diagnostic test accuracy for COVID-19 by mass spectrometry. Metabolism. 2022;126 doi: 10.1016/j.metabol.2021.154922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2021.154922</ArticleId><ArticleId IdType="pmc">PMC8548837</ArticleId><ArticleId IdType="pubmed">34715115</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K., Del Prato S., Mathieu C., Kahn S.E., Gabbay R.A., Buse J.B. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021;44(12):2645&#x2013;2655. doi: 10.2337/dc21-1318.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1318</ArticleId><ArticleId IdType="pmc">PMC8669536</ArticleId><ArticleId IdType="pubmed">34625431</ArticleId></ArticleIdList></Reference><Reference><Citation>Iughetti L., Trevisani V., Cattini U., et al. COVID-19 and type 1 diabetes: concerns and challenges. Acta Biomed. 2020;91(3) doi: 10.23750/abm.v91i3.10366.</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i3.10366</ArticleId><ArticleId IdType="pmc">PMC7716973</ArticleId><ArticleId IdType="pubmed">32921727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P., Zhang Y., Witmer L., Chinchilli V.M., Ba D.M. Association of COVID-19 with diabetes: a systematic review and meta-analysis. Res Square. 2022 doi: 10.21203/rs.3.rs-1848430/v1. (preprint)</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1848430/v1</ArticleId><ArticleId IdType="pmc">PMC9684130</ArticleId><ArticleId IdType="pubmed">36418912</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee M., Pal R., Dutta S. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Prim Care Diabetes. 2022;16(4):591&#x2013;593. doi: 10.1016/j.pcd.2022.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcd.2022.05.009</ArticleId><ArticleId IdType="pmc">PMC9148988</ArticleId><ArticleId IdType="pubmed">35654679</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.T., Lidsky P.V., Xiao Y., et al. SARS-CoV-2 infects human pancreatic &#x3b2; cells and elicits &#x3b2; cell impairment. Cell Metab. 2021;33(8):1565&#x2013;1576.e5. doi: 10.1016/j.cmet.2021.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC8130512</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Roep B.O., Thomaidou S., van Tienhoven R., Zaldumbide A. Type 1 diabetes mellitus as a disease of the &#x3b2;-cell (do not blame the immune system?) Nat Rev Endocrinol. 2021;17(3):150&#x2013;161. doi: 10.1038/s41574-020-00443-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00443-4</ArticleId><ArticleId IdType="pmc">PMC7722981</ArticleId><ArticleId IdType="pubmed">33293704</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.K., Lin S.S., Ji X.J., Guo L.M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47(3):193&#x2013;199. doi: 10.1007/s00592-009-0109-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00592-009-0109-4</ArticleId><ArticleId IdType="pmc">PMC7088164</ArticleId><ArticleId IdType="pubmed">19333547</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R., Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027&#x2013;1031. doi: 10.1007/s40618-020-01276-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01276-8</ArticleId><ArticleId IdType="pmc">PMC7195612</ArticleId><ArticleId IdType="pubmed">32361826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain A., Bhowmik B., do Vale Moreira N.C. COVID-19 and diabetes: knowledge in progress. Diabetes Res Clin Pract. 2020;162(108142) doi: 10.1016/j.diabres.2020.108142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108142</ArticleId><ArticleId IdType="pmc">PMC7144611</ArticleId><ArticleId IdType="pubmed">32278764</ArticleId></ArticleIdList></Reference><Reference><Citation>Coate K.C., Cha J., Shrestha S., et al. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in &#x3b2; cells. Cell Metab. 2020;32(6):1028&#x2013;1040.e4. doi: 10.1016/j.cmet.2020.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.11.006</ArticleId><ArticleId IdType="pmc">PMC7664344</ArticleId><ArticleId IdType="pubmed">33207245</ArticleId></ArticleIdList></Reference><Reference><Citation>Pranata R., Henrina J., Raffaello W.M., Lawrensia S., Huang I. Diabetes and COVID-19: the past, the present, and the future. Metabolism. 2021;121 doi: 10.1016/j.metabol.2021.154814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2021.154814</ArticleId><ArticleId IdType="pmc">PMC8192264</ArticleId><ArticleId IdType="pubmed">34119537</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>